epithelial Sodium Channel alpha (SCNN1A) Rabbit Polyclonal Antibody

CAT#: TA890149S

Rabbit Polyclonal anti-SCNN1A Antibody

Size: 30 ul 100 ul



 

Need it in bulk or conjugated?
Get a free quote

CNY 800.00


货期*
现货

规格
    • 30 ul

Product images

经常一起买 (2)
beta Actin Mouse Monoclonal Antibody, Clone OTI1, Loading Control
    • 30 ul

CNY 300.00
CNY 1,430.00


Transient overexpression lysate of sodium channel, nonvoltage-gated 1 alpha (SCNN1A), transcript variant 1
    • 100 ug

CNY 3,080.00

Specifications

Product Data
Applications WB
Recommend Dilution WB: 1:500~2000
Reactivity Human
Host Rabbit
Clonality Polyclonal
Immunogen Recombinant protein of human SCNN1A
Formulation PBS with 0.02% sodium azide, 50% glycerol, pH7.3
Concentration 1.93 mg/ml
Purification Purified from the immunized serum by affinity chromatography (Protein A/G)
Conjugation Unconjugated
Storage Condition Store at -20°C as received.
Predicted Protein Size 75.5 kDa
Gene Name sodium channel epithelial 1 alpha subunit
Background Nonvoltage-gated, amiloride-sensitive, sodium channels control fluid and electrolyte transport across epithelia in many organs. These channels are heteromeric complexes consisting of 3 subunits: alpha, beta, and gamma. This gene encodes the alpha subunit, and mutations in this gene have been associated with pseudohypoaldosteronism type 1 (PHA1), a rare salt wasting disease resulting from target organ unresponsiveness to mineralocorticoids. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2009]
Synonyms BESC2; ENaCa; ENaCalpha; SCNEA; SCNN1
Reference Data
Protein Families Druggable Genome, Ion Channels: Other, Transmembrane
Protein Pathways Taste transduction
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Other Versions

其它epithelial Sodium Channel alpha产品

Customer Reviews 
Loading...